By Counterforce Health Team in Galafold (migalastat) —

If Galafold (Migalastat) Isn't Approved by Aetna (CVS Health) in Texas: Formulary Alternatives & Exception Paths

Quick Answer: If Aetna (CVS Health) denies Galafold (migalastat) in Texas, your main formulary alternatives are Fabrazyme (agalsidase beta) and Replagal (agalsidase alfa). For Galafold exceptions, you'll need genetic testing proving an amenable GLA variant, specialist documentation, and evidence of ERT contraindication or failure. File internal appeals within 180 days, then pursue Texas IRO external review if denied. Start by requesting your genetic test results and scheduling with a Fabry specialist today.

Table of Contents

When Alternatives Make Sense

Galafold (migalastat) requires strict prior authorization from Aetna (CVS Health), and coverage is limited to adults with confirmed amenable GLA variants. If your initial request is denied or you're looking to avoid the complex approval process, formulary alternatives may be appropriate.

Consider alternatives when:

  • Genetic testing hasn't confirmed an amenable GLA variant
  • You have severe kidney impairment (eGFR < 30 mL/min/1.73m²)
  • Your doctor recommends starting with enzyme replacement therapy (ERT)
  • Prior authorization delays are affecting your treatment timeline

Stick with Galafold exception requests when:

  • You have a confirmed amenable GLA mutation
  • You've failed or can't tolerate ERT infusions
  • Oral therapy is medically necessary for your situation

Aetna's Formulary Alternatives for Fabry Disease

Aetna (CVS Health) prefers enzyme replacement therapies as first-line treatment for Fabry disease:

Primary Alternatives

Fabrazyme (agalsidase beta)

  • Coverage: Widely covered on Aetna formularies
  • Administration: IV infusion every 2 weeks (1 mg/kg)
  • Requirements: Specialist prescription, confirmed Fabry diagnosis
  • Prior authorization: Required but typically approved for appropriate candidates

Replagal (agalsidase alfa)

  • Coverage: Less commonly covered than Fabrazyme
  • Administration: IV infusion every 2 weeks (0.2 mg/kg)
  • Availability: May require formulary exception in some plans

Coverage Requirements Table

Treatment Formulary Status Age Requirement Specialist Needed Genetic Testing
Fabrazyme Preferred ≥2 years Yes (metabolic/genetics) Fabry confirmation
Replagal Variable coverage ≥2 years Yes (metabolic/genetics) Fabry confirmation
Galafold Exception required ≥18 years Yes (multiple specialties) Amenable variant required

Pros and Cons Overview

Enzyme Replacement Therapy (ERT) Advantages

  • Established coverage: Fabrazyme has preferred formulary status
  • Broad effectiveness: Works regardless of GLA mutation type
  • Clinical experience: Decades of real-world use and monitoring
  • Age flexibility: Approved for pediatric patients (≥2 years)

ERT Considerations

  • Infusion requirements: Hospital or infusion center visits every 2 weeks
  • Time commitment: 3-4 hours per infusion including monitoring
  • Infusion reactions: Fever, chills, and allergic reactions possible
  • Antibody development: May reduce effectiveness over time

Galafold (SRT) Advantages

  • Oral administration: Take at home every other day
  • No infusion reactions: Avoids IV-related complications
  • Convenient dosing: 123 mg capsules with specific fasting requirements

Galafold Considerations

  • Limited eligibility: Only works for amenable GLA variants
  • Complex approval: Extensive documentation requirements
  • Renal restrictions: Cannot use with severe kidney impairment
  • Higher cost: Approximately $360,000-$400,000 annually
From our advocates: "We've seen families successfully transition from ERT to Galafold after documenting infusion reactions and confirming amenable mutations. The key was having their metabolic specialist document every infusion reaction and coordinate genetic testing through a certified lab. While not guaranteed, this comprehensive approach helped build a strong exception case."

Exception Strategy for Galafold

If Galafold is your medically preferred option, focus on building a bulletproof exception request:

Essential Documentation

Genetic Testing Requirements

Clinical Documentation

  • Specialist evaluation from genetics, nephrology, or metabolic medicine
  • Detailed Fabry disease symptoms and organ involvement
  • Current eGFR and kidney function tests
  • Documentation of ERT trial/failure or contraindications

Medical Necessity Letter Components

  1. Confirmed Fabry disease diagnosis with genetic proof
  2. Amenable GLA variant specification
  3. Clinical rationale for substrate reduction vs. enzyme replacement
  4. Previous treatment history and outcomes
  5. Contraindications to alternative therapies
  6. Expected treatment response and monitoring plan

Submission Process

Submit prior authorization via Aetna provider portal or fax to 1-888-267-3277. Include:

  • Completed prior authorization form
  • All genetic and clinical documentation
  • Specialist letter of medical necessity
  • Lab results showing kidney function

Timeline expectations:

  • Standard review: 30-45 days
  • Expedited review: 72 hours if urgent

Switching Logistics

Coordinating with Your Care Team

Before switching treatments:

  1. Discuss timing with your Fabry specialist
  2. Review monitoring requirements for new therapy
  3. Coordinate pharmacy (specialty pharmacy for ERT, CVS Specialty for Galafold)
  4. Plan infusion scheduling if moving to ERT

Pharmacy Coordination

For ERT (Fabrazyme/Replagal):

  • Coordinate with CVS Specialty Pharmacy or approved infusion pharmacy
  • Schedule infusion center appointments
  • Arrange pre-medications if needed

For Galafold:

  • Must use CVS Specialty Pharmacy: 1-800-237-2767
  • Confirm fasting requirements and dosing schedule
  • Set up adherence monitoring
Tip: Don't stop your current Fabry treatment until new therapy is approved and ready to start. Treatment gaps can lead to symptom progression.

Re-trying for Galafold Later

If you start with ERT but want to pursue Galafold later, document everything:

What to Track During ERT

  • Infusion reactions: Date, severity, treatments required
  • Quality of life impacts: Time off work, travel limitations
  • Clinical response: GL-3 levels, organ function, symptoms
  • Antibody development: Anti-drug antibody testing results

Building Your Case

After 6-12 months of ERT, you can request Galafold if you have:

  • Documented infusion reactions or intolerance
  • Confirmed amenable GLA variant
  • Stable or inadequate clinical response to ERT
  • Quality of life concerns with infusion schedule

Counterforce Health specializes in turning insurance denials into targeted appeals for complex medications like Galafold. Their platform analyzes denial letters and crafts evidence-backed rebuttals aligned to payer policies, helping patients navigate the complex prior authorization process with the right clinical documentation and procedural requirements.

Appeals Process in Texas

If your Galafold exception is denied, Texas provides strong appeal rights:

Internal Appeal Timeline

  • File within: 180 days of denial notice
  • Review time: 30 days standard, 72 hours expedited
  • Submit to: Aetna member services or provider portal

External Review (IRO)

After internal appeal denial:

  • File within: 4 months of final adverse determination
  • Review time: 45 days standard, 72 hours expedited
  • Contact: Texas Department of Insurance at 1-800-252-3439

Required Appeal Documentation

  • Copy of original denial letter
  • All medical records and genetic testing
  • Updated specialist letter addressing denial reasons
  • Evidence of medical necessity specific to Galafold

Common Questions

How long does Aetna prior authorization take for Galafold in Texas? Standard reviews take 30-45 days. Expedited reviews are completed within 72 hours if treatment delays would jeopardize health.

What if Galafold is non-formulary on my plan? You can request a formulary exception with medical necessity documentation. Success depends on proving clinical superiority over covered alternatives and providing comprehensive genetic/clinical evidence.

Can I get expedited appeals for Galafold denials? Yes, if treatment delay would seriously jeopardize your health. Mark all submissions as "expedited" and provide clinical justification for urgency.

Does step therapy apply if I haven't tried ERT? Aetna typically requires ERT trial or documented contraindication before approving Galafold. Your specialist must justify why ERT isn't appropriate.

What genetic testing labs does Aetna accept? Any CLIA-certified laboratory can perform GLA variant testing. Ensure the report specifically identifies amenable variants per FDA labeling requirements.

How much does Galafold cost without insurance? List price is approximately $30,025 per 14-capsule supply, equivalent to $360,000-$400,000 annually. Patient assistance programs may be available through Amicus Therapeutics.

For additional support navigating complex prior authorizations and appeals, Counterforce Health provides specialized assistance in turning insurance denials into successful approvals through targeted, evidence-backed documentation.

Sources & Further Reading

This guide is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider and insurance plan for personalized guidance. For assistance with insurance appeals in Texas, contact the Texas Department of Insurance at 1-800-252-3439 or visit their website for current resources and complaint procedures.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.